CEP350

Across TCGA pan-cancer cohorts, CEP350 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CEP350’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where CEP350 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types CEP350 is over-expressed in tumor, although a few such as HNSC and COAD show the opposite, repressed pattern.

LSCC, HNSC, and COAD are the cancer types where CEP350 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CEP350 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	Female	III,IV	+0.240	<.001	8	view →
HNSC	All	III,IV	−0.208	.001	7	view →
COAD	Female	All	−0.487	.013	2	view →
PDAC	All	II,III,IV	−0.187	.022	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

CEP350–LSCC

Open the LSCC breakdown →